Most people who initiated semaglutide received the injectable form (T2D: 87.5%
1 Endocrinology, Abdominal Center, Helsinki University Hospital, Helsinki, Finland, 2 Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland, 3 Research Program of Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland, 4 Folkhlsan Research Centre, Helsinki, Finland
As always, your healthcare provider is your best resource for personalized advice and support throughout your treatment journey
Our discoveries have the potential to change whats medically possible within our lifetimes
These effects are usually manageable by increasing the dose gradually and staying well hydrated, which is why supervised dosing schedules matter
Any reference to biological activity or potential effects is based solely on preclinical or in vitro findings and should not be interpreted as validated clinical outcomes